课题基金 / 基金详情

Statistical Methods for Selection and Evaluation of Biomarkers

Statistical Methods for Selection and Evaluation of Biomarkers
生物标志物选择和评价的统计方法
批准号:
8660307
负责人:
Ying Huang
金额:
$32.44万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-05-10 至 2018-01-31

项目摘要

项目成果

Ying Huang的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Recent advances in the laboratory sciences have led to the discovery of a large number of candidate biomarkers, which hold great potential for disease diagnosis and treatment. At this time, an important research bottleneck is the lack of well-developed statistical methods for effectively using these candidate biomarkers to enhance clinical practice. It is our goal to develop new tools to select, combine, and evaluate biomarkers for disease classification and treatment selection. Classification markers predict an individual's disease outcome and are useful for the detection of diseases at an early stage when a treatment is most effective. Research proposed in Aim 1 seeks to select and combine markers to improve the classification performance in disease screening and diagnosis. Treatment selection markers predict a patient's response to different therapies and allow for the selection of a therapy that has the best predicted outcome. Aim 2 seeks to develop marker-based treatment selection rules to maximize the benefit to the patient population. A biomarker that is useful for guiding treatment decision to the general population will have different values to different patients due to individual differences in their response to treatment and in their tolerance of the disease harm and treatment cost. Aim 3 seeks to develop a new graphical tool to customize the evaluation of a biomarker for aiding treatment decision based on personal characteristics. Our statistical methods will apply broadly to general medical fields. In particulr, we will apply these methods to analyze several cancer studies including (1) biomarker studies for prostate cancer and pan- creatic cancer from the Early Detection and Research Network; (2) the Women's Health Initiative breast cancer genome-wide association study; and (3) the Oncotype-Dx breast cancer study from the Southwest Oncology Group. Programs and algorithms developed in this proposal will be made available to public.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Accelerating biomarker development through novel statistical methods for analyzing phase III/IV studies
  • 批准号:
    10568744
  • 项目类别:
  • 资助金额:
    $41.34万
  • 财政年份:
    2022
  • 负责人:
    Ying Huang
  • 依托单位:
Preventing UV-induced immunosuppression and skin carcinogenesis with R-carvedilol
Preventing UV-induced immunosuppression and skin carcinogenesis with R-carvedilol
Chemoprevention of lung cancer with the β-blocker carvedilol
海外基金